Cargando…

Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer

BACKGROUND: There are numerous factors to consider in deciding whether to undergo surgical treatment for brain metastasis from lung cancer. Herein, we aimed to analyze the survival outcome and predictors of recurrence of surgically treated brain metastasis from non-small cell lung cancer (NSCLC). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Joonho, Kim, Jong Hyun, Kim, Moinay, Lee, Seungjoo, Kim, Young-Hoon, Hong, Chang Ki, Kim, Jeong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353167/
https://www.ncbi.nlm.nih.gov/pubmed/35929115
http://dx.doi.org/10.14791/btrt.2022.0016
_version_ 1784762815669600256
author Byun, Joonho
Kim, Jong Hyun
Kim, Moinay
Lee, Seungjoo
Kim, Young-Hoon
Hong, Chang Ki
Kim, Jeong Hoon
author_facet Byun, Joonho
Kim, Jong Hyun
Kim, Moinay
Lee, Seungjoo
Kim, Young-Hoon
Hong, Chang Ki
Kim, Jeong Hoon
author_sort Byun, Joonho
collection PubMed
description BACKGROUND: There are numerous factors to consider in deciding whether to undergo surgical treatment for brain metastasis from lung cancer. Herein, we aimed to analyze the survival outcome and predictors of recurrence of surgically treated brain metastasis from non-small cell lung cancer (NSCLC). METHODS: A total of 197 patients with brain metastasis from NSCLC who underwent microsurgery were included in this study. RESULTS: A total of 114 (57.9%) male and 83 (42.1%) female patients with a median age of 59 years (range, 27–79) was included in this study. The median follow-up period was 22.7 (range, 1–126) months. The 1-year and 2-year overall survival (OS) rates of patients with brain metastasis secondary to NSCLC were 59% and 43%, respectively. The 6-month and 1-year progression-free survival (PFS) rates of local recurrence were 80% and 73%, respectively, whereas those of distant recurrence were 84% and 63%, respectively. En-bloc resection of tumor resulted in better PFS for local recurrence (1-year PFS: 79% vs. 62%, p=0.02). Ventricular opening and direct contact between the tumor and the subarachnoid space were not associated with distal recurrence and leptomeningeal seeding. The difference in PFS of local recurrence according to adjuvant resection bed irradiation was not significant. Moreover, postoperative whole-brain irradiation did not show a significant difference in PFS of distant recurrence. In multivariate analysis, only en-bloc resection was a favorable prognostic factor for local recurrence. Contrastingly, multiple metastasis was a poor prognostic factor for distant recurrence. CONCLUSION: En-bloc resection may reduce local recurrence after surgical resection. Ventricular opening and contact between the tumor and subarachnoid space did not show a statistically significant result for distant recurrence and leptomeningeal seeding. Multiple metastasis was only meaningful factor for distant recurrence.
format Online
Article
Text
id pubmed-9353167
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
record_format MEDLINE/PubMed
spelling pubmed-93531672022-08-12 Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer Byun, Joonho Kim, Jong Hyun Kim, Moinay Lee, Seungjoo Kim, Young-Hoon Hong, Chang Ki Kim, Jeong Hoon Brain Tumor Res Treat Original Article BACKGROUND: There are numerous factors to consider in deciding whether to undergo surgical treatment for brain metastasis from lung cancer. Herein, we aimed to analyze the survival outcome and predictors of recurrence of surgically treated brain metastasis from non-small cell lung cancer (NSCLC). METHODS: A total of 197 patients with brain metastasis from NSCLC who underwent microsurgery were included in this study. RESULTS: A total of 114 (57.9%) male and 83 (42.1%) female patients with a median age of 59 years (range, 27–79) was included in this study. The median follow-up period was 22.7 (range, 1–126) months. The 1-year and 2-year overall survival (OS) rates of patients with brain metastasis secondary to NSCLC were 59% and 43%, respectively. The 6-month and 1-year progression-free survival (PFS) rates of local recurrence were 80% and 73%, respectively, whereas those of distant recurrence were 84% and 63%, respectively. En-bloc resection of tumor resulted in better PFS for local recurrence (1-year PFS: 79% vs. 62%, p=0.02). Ventricular opening and direct contact between the tumor and the subarachnoid space were not associated with distal recurrence and leptomeningeal seeding. The difference in PFS of local recurrence according to adjuvant resection bed irradiation was not significant. Moreover, postoperative whole-brain irradiation did not show a significant difference in PFS of distant recurrence. In multivariate analysis, only en-bloc resection was a favorable prognostic factor for local recurrence. Contrastingly, multiple metastasis was a poor prognostic factor for distant recurrence. CONCLUSION: En-bloc resection may reduce local recurrence after surgical resection. Ventricular opening and contact between the tumor and subarachnoid space did not show a statistically significant result for distant recurrence and leptomeningeal seeding. Multiple metastasis was only meaningful factor for distant recurrence. The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2022-07 2022-07-28 /pmc/articles/PMC9353167/ /pubmed/35929115 http://dx.doi.org/10.14791/btrt.2022.0016 Text en Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Byun, Joonho
Kim, Jong Hyun
Kim, Moinay
Lee, Seungjoo
Kim, Young-Hoon
Hong, Chang Ki
Kim, Jeong Hoon
Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title_full Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title_fullStr Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title_full_unstemmed Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title_short Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
title_sort survival outcomes and predictors for recurrence of surgically treated brain metastasis from non-small cell lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353167/
https://www.ncbi.nlm.nih.gov/pubmed/35929115
http://dx.doi.org/10.14791/btrt.2022.0016
work_keys_str_mv AT byunjoonho survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT kimjonghyun survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT kimmoinay survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT leeseungjoo survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT kimyounghoon survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT hongchangki survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer
AT kimjeonghoon survivaloutcomesandpredictorsforrecurrenceofsurgicallytreatedbrainmetastasisfromnonsmallcelllungcancer